Triamcinalone
Knee Arthritis
Hildrun HaibelPhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Knee Arthritis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ROPIVACAINE Poznan University of Medical Sciences | Phase 4 | BBB |
NEPENTHE Poznan University of Medical Sciences | Phase 4 | BB |
Bxcl501 Poznan University of Medical Sciences | Phase 4 | BB |
DEXAMETHASONE Poznan University of Medical Sciences | Phase 4 | BB |
DEXKETOPROFEN Poznan University of Medical Sciences | Phase 4 | BB |
View all 10 →
Same molecule, other indications
Triamcinalone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →